Apollon Wealth Management LLC Raises Stock Holdings in Aflac Incorporated (NYSE:AFL)

Apollon Wealth Management LLC raised its position in shares of Aflac Incorporated (NYSE:AFL) by 5.5% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 30,859 shares of the financial services provider’s stock after purchasing an additional 1,602 shares during the quarter. Apollon Wealth Management LLC’s holdings in Aflac were worth $3,450,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in AFL. Y.D. More Investments Ltd purchased a new stake in Aflac in the second quarter valued at approximately $25,000. Covestor Ltd boosted its holdings in shares of Aflac by 41.8% in the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock valued at $41,000 after acquiring an additional 107 shares during the last quarter. Kennebec Savings Bank purchased a new stake in shares of Aflac in the 3rd quarter valued at $45,000. Cedar Wealth Management LLC acquired a new stake in shares of Aflac in the first quarter worth $50,000. Finally, Catalyst Capital Advisors LLC purchased a new position in shares of Aflac during the third quarter worth $51,000. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Wall Street Analysts Forecast Growth

AFL has been the topic of several analyst reports. Truist Financial increased their price target on Aflac from $100.00 to $105.00 and gave the stock a “hold” rating in a research report on Friday, November 1st. JPMorgan Chase & Co. lifted their price target on Aflac from $85.00 to $90.00 and gave the company a “neutral” rating in a research report on Thursday, October 3rd. TD Cowen assumed coverage on Aflac in a research report on Wednesday, October 9th. They issued a “hold” rating and a $102.00 price objective on the stock. Barclays initiated coverage on shares of Aflac in a report on Wednesday, September 4th. They set an “underweight” rating and a $96.00 target price for the company. Finally, Citigroup increased their price target on shares of Aflac from $84.00 to $93.00 and gave the stock a “neutral” rating in a report on Tuesday, July 23rd. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $97.93.

Aflac Stock Performance

NYSE AFL opened at $110.68 on Wednesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.08 and a quick ratio of 0.10. The stock’s 50 day simple moving average is $110.33 and its 200-day simple moving average is $98.95. The company has a market cap of $61.49 billion, a PE ratio of 16.67, a price-to-earnings-growth ratio of 2.10 and a beta of 0.96. Aflac Incorporated has a 1-year low of $75.07 and a 1-year high of $115.50.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.69 by $0.47. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The company had revenue of $2.95 billion for the quarter, compared to analyst estimates of $4.30 billion. During the same quarter last year, the firm posted $1.84 EPS. The firm’s revenue for the quarter was down 40.4% on a year-over-year basis. As a group, equities research analysts anticipate that Aflac Incorporated will post 7.17 EPS for the current fiscal year.

Aflac Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be issued a $0.50 dividend. The ex-dividend date is Wednesday, November 20th. This represents a $2.00 dividend on an annualized basis and a yield of 1.81%. Aflac’s payout ratio is 30.12%.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.